<DOC>
	<DOCNO>NCT00602134</DOCNO>
	<brief_summary>The objective study assess bioequivalence potential generic 6-mercaptopurine 50 mg tablet formulation compare GlaxoSmithKline PurinetholÂ® ( mercaptopurine ) 50-mg scored tablet follow single 50 mg oral dose administer fasted state .</brief_summary>
	<brief_title>Bioequivalence Study 6-Mercaptopurine Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<criteria>No clinically significant abnormal finding physical examination , medical history , clinical laboratory result . Must voluntarily consent . Must known history thiopurine methyltransferase deficiency family history . Must history elevate uric acid gout . Must currently use allopurinol .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>